5 hours NovoCure (NASDAQ:NVCR) Given New $18.00 Price Target at Evercore ISI MarketBeat
Evercore ISI reduced their price target on shares of NovoCure from $21.00 to $18.00 and set an “in-line” rating on the stock in a report on Tuesday.
Evercore ISI reduced their price target on shares of NovoCure from $21.00 to $18.00 and set an “in-line” rating on the stock in a report on Tuesday.